ClinicalTrials.gov
ClinicalTrials.gov Menu

An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00299676
Recruitment Status : Completed
First Posted : March 7, 2006
Last Update Posted : May 23, 2014
Sponsor:
Information provided by (Responsible Party):
Janssen-Cilag Pty Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2008
  Actual Study Completion Date : March 2008